HDAC6 is upregulated in corneal diseases and causes ENKD1 deacetylation at lysine 98. Deacetylation of ENKD1 blocks its ...
Patients with Fuchs endothelial corneal dystrophy with particular genetic markers are at higher risk for surgery and vision loss.
The mum of an 11-year-old boy who is waiting to find out if he can access a new drug to treat his Duchenne muscular dystrophy (DMD) said her son talked about his fear of death. Harry, from Corby ...
Surgeons restored corneal surfaces in the injured eyes of 14 patients in a small clinical trial. Stem cells from each patient’s healthy eye were cultivated in a lab to grow healthy tissue that could ...
Eye injuries that damage the cornea are usually irreversible and cause blindness. But a new clinical trial has repaired this damage in patients thanks to a transplant of stem cells from their ...
When a person's cornea is damaged, the injury can deplete the limbal epithelial cells. As a result, the surface of the eye develops permanent damage -- a condition called limbal stem cell deficiency.
WEDNESDAY, March 5, 2025 (HealthDay News) -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. The cornea -- the clear ...
The study uncovers the molecular 'rules' driving the arrangement of emerin into nanoclusters and the mechanisms leading to their defective assembly in people with muscular dystrophy. A new ...
Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers ...
Get Instant Summarized Text (Gist) A clinical trial tested a stem cell therapy, CALEC, for corneal injuries, showing it is feasible and safe. The treatment restored the cornea's surface in 50% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results